Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.

Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.

Item
http://www.wikidata.org/entity/Q34596937
Systematic review: the efficacy of herbal therapy in inflammatory bowel diseaseOpportunities to assess factors contributing to the development of the intestinal microbiota in infants living in developing countries.Monocolonization of germ-free mice with Bacteroides fragilis protects against dextran sulfate sodium-induced acute colitis.Effects of an Oral Supplementation of Germinated Barley Foodstuff on Serum CRP Level and Clinical Signs in Patients with Ulcerative Colitis.Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy.The bifidogenic effect of inulin and oligofructose and its consequences for gut health.Dysbiotic bacteria translocate in progressive SIV infection.Microbial translocation and microbiome dysbiosis in HIV-associated immune activationPurification of Antilisterial Peptide (Subtilosin A) from Novel Bacillus tequilensis FR9 and Demonstrate Their Pathogen Invasion Protection Ability Using Human Carcinoma Cell Line.Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques.Probiotics and their derivatives as treatments for inflammatory bowel disease.Emerging drugs to treat Crohn's disease.Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum".Aberrant response to commensal Bacteroides thetaiotaomicron in Crohn's disease: an ex vivo human organ culture study.Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic update.Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity.GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet, February 2nd 2015
P2860

Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.

Item
http://www.wikidata.org/entity/Q34596937
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@ast
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@en
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@nl
type
label
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@ast
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@en
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@nl
prefLabel
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@ast
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@en
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Manipulation of intestinal mic ...... s, pre-biotics and synbiotics.
@en
P2093
P304
P31
P356
10.2174/157488708785700302
P433
P478
P577
P698
P921